112 related articles for article (PubMed ID: 1472934)
21. Cyclosporin A inhibits cytokine-induced proliferation in B-chronic lymphocytic leukemia.
Schmid M; Merk B; Porzsolt F
Leuk Lymphoma; 1994 Oct; 15(3-4):317-25. PubMed ID: 7866281
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.
Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F
Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Vedantham S; Gamliel H; Golomb HM
Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Khalaf W; Maina C; Byers J; Harvey W
Leuk Res; 2002 Feb; 26(2):169-77. PubMed ID: 11755467
[TBL] [Abstract][Full Text] [Related]
25. Protein-tyrosine phosphatase activity maintains the viability of hairy cells and modulates their response to interferon-alpha.
Allsup D; Harris R; Baker P; Cawley J
Leuk Lymphoma; 2008 Dec; 49(12):2351-8. PubMed ID: 19052984
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
[TBL] [Abstract][Full Text] [Related]
27. Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation.
Sgarabotto D; Zerbinati P; Vianello F; Valeri P; Girolami A; Dazzi F
Haematologica; 1992; 77(4):367-8. PubMed ID: 1427450
[No Abstract] [Full Text] [Related]
28. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia.
Kluin-Nelemans JC; Kester MG; Oving I; Cluitmans FH; Willemze R; Falkenburg JH
Leukemia; 1994 Dec; 8(12):2095-101. PubMed ID: 7807997
[TBL] [Abstract][Full Text] [Related]
29. [Hairy-cell leukemia as a model for studying the effects of interferon on the immune system].
Semenzato G; Trentin L; Bulian P; Agostini C; Chisesi T; Pizzolo G
Haematologica; 1990; 75 Suppl 4():10-9. PubMed ID: 1705910
[No Abstract] [Full Text] [Related]
30. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
Perussia B; Chan SH; D'Andrea A; Tsuji K; Santoli D; Pospisil M; Young D; Wolf SF; Trinchieri G
J Immunol; 1992 Dec; 149(11):3495-502. PubMed ID: 1358972
[TBL] [Abstract][Full Text] [Related]
31. Paracrine regulation of B-cell growth in hairy cell leukemia.
Porzsolt F; Schmid M; Staib G; Schrezenmeier H
Leuk Lymphoma; 1994; 14 Suppl 1():13-8. PubMed ID: 7820045
[TBL] [Abstract][Full Text] [Related]
32. Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells.
Genot E; Wietzerbin J
Leuk Lymphoma; 1994; 14 Suppl 1():23-6. PubMed ID: 7820049
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of action of interferon-alpha 2 in hairy cells and lymphoblastoid cell lines: the significance of type I interferon receptors and RNA synthesis].
Schwabe M; Wagner L; Prischl F; Pinter G; Schwarzmeier JD
Onkologie; 1988 Aug; 11(4):155-8. PubMed ID: 2972979
[TBL] [Abstract][Full Text] [Related]
35. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
[TBL] [Abstract][Full Text] [Related]
36. Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.
Lauria F; Rondelli D; Raspadori D; Zinzani PL; Benfenati D; Pileri S; Sabattini E; Tura S
Leuk Lymphoma; 1992 May; 7(1-2):103-7. PubMed ID: 1472920
[TBL] [Abstract][Full Text] [Related]
37. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
[TBL] [Abstract][Full Text] [Related]
38. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
[TBL] [Abstract][Full Text] [Related]
39. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P
Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440
[TBL] [Abstract][Full Text] [Related]
40. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia.
Semenzato G; Trentin L; Zambello R; Agostini C; Bulian P; Siviero F; Ambrosetti A; Vinante F; Prior M; Chilosi M
Leukemia; 1988 Dec; 2(12):788-92. PubMed ID: 3264362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
